Skip to main content

Peer Review reports

From: Informed consent in cancer clinical drug trials in China: a narrative literature review of the past 20 years

Original Submission
26 Apr 2022 Submitted Original manuscript
7 Aug 2022 Reviewed Reviewer Report - Prashant Musmade
13 Sep 2022 Reviewed Reviewer Report - Yonghui Ma
17 Sep 2022 Reviewed Reviewer Report - Jingbao Nie
1 Feb 2023 Author responded Author comments - xiaomin wang
Resubmission - Version 2
1 Feb 2023 Submitted Manuscript version 2
15 Feb 2023 Reviewed Reviewer Report - Yonghui Ma
21 Feb 2023 Reviewed Reviewer Report - Jingbao Nie
14 Apr 2023 Reviewed Reviewer Report - Peter Knapp
16 Apr 2023 Reviewed Reviewer Report - Daniel Semakula
1 May 2023 Reviewed Reviewer Report - Ojeiu Ejere
5 Jun 2023 Author responded Author comments - xiaomin wang
Resubmission - Version 3
5 Jun 2023 Submitted Manuscript version 3
12 Jun 2023 Reviewed Reviewer Report - Ojeiu Ejere
27 Jun 2023 Reviewed Reviewer Report - Jingbao Nie
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
27 Jun 2023 Editorially accepted
7 Jul 2023 Article published 10.1186/s13063-023-07482-y

You can find further information about peer review here.

Back to article page